Stock Price of Novartis AG (NVS) Increases 2.33%

Stock price performance of Novartis AG is analyzed for various periods using several stock trading signals. In this case, The stock price has rallied 0.54% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -9.16% . Looking at the past 52 week period, the stock price is down -0.59% . Relative price strength is a important factor used by wealth management firms while investing in stocks because the indicator compares the stock performance with the overall market. The relative price strength of Novartis AG has a positive value of 0.55 compared to overall market. For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a 20-day Moving Average of 0.08% and the 50-Day Moving Average is 1.62%.The 200 Day SMA reached 5.83%

Novartis AG is having a Relative Strength Index of 61.78 which indicates the stock is not yet over sold or over bought based on the technical indicators. Novartis AG (NYSE:NVS) has climbed 2.33% in the past week and advanced 0.54% in the last 4 weeks. The company has outperformed the S&P 500 by 2.21% in the past week but underperformed the index by 0.35% in the last 4 weeks.

Novartis AG (ADR) Last issued its quarterly earnings results on Jan 25, 2017. The company reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $1.12. The company had revenue of $12322.00 million for the quarter, compared to analysts expectations of $12440.65 million. The companys revenue was down -1.6 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.12 EPS.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.Novartis AG (ADR) was Downgraded by Berenberg to Hold on Jan 17, 2017. Novartis AG (ADR) was Downgraded by Credit Suisse to Neutral on Jan 11, 2017. Novartis AG (ADR) was Upgraded by Argus to Buy on Nov 10, 2016.

Novartis AG (NYSE:NVS) : On Friday heightened volatility was witnessed in Novartis AG (NYSE:NVS) which led to swings in the share price. The stock opened for trading at $73.62 and hit $73.97 on the upside , eventually ending the session at $73.89, with a gain of 1.11% or 0.81 points. The heightened volatility saw the trading volume jump to 3,019,758 shares. The 52-week high of the share price is $83.58 and the company has a market cap of $175,419 million. The 52-week low of the share price is at $66.93 .

Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders – their customers, their people, their shareholders and the communities in which they live and work.

Novartis

Share this post

Leave a Reply